ETFsMSCI China Tech IMI All Share Stock Connect Filtered Index
Amundi
Amundi MSCI China Tech UCITS ETF EUR
CC1 PAPhysical, full replicationLuxembourgNot PEA-eligible
Last close · EUR
238.35EUR
-1.24% · -€3.00
Published closes: 29 Oct 2026 - 30 Oct 2026
30 Oct 2026, close
CC1Base
- Fund charges
- 0.55%Total expense ratio (TER)
- Fund size
- €191.1Mall share classes
- Return 1Y
- -25.8%
- Sharpe 3Y
- 0.11
- Volatility 1Y
- 18.9%annualised
- Holdings
- 94Fund holdings
Performance
Compare
- CC1-25.8%
- Price, EUR
Returns
| Returns | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|
| CC1 | -7.0% | -12.6% | -18.9% | -18.2% | -25.8% | +6.8% | -9.3% |
| MSCI World | +0.4% | +4.9% | +10.8% | +16.3% | +15.9% | +75.5% | +71.2% |
| Gap to MSCI World | -7.5% | -17.5% | -29.7% | -34.5% | -41.7% | -68.7% | -80.5% |
Risk and return
Sharpe ratio · 3Y
0.11
Below MSCI World · 1.24- Return p.a.
- +2.0%
- Volatility
- 28.2%
- Max loss
- -27.4%Apr 2025
Sharpe vs indices
MSCI World
1.24
S&P 500
1.21
STOXX Europe 600
1.04
MSCI Emerging Markets IMI
0.93
CAC 40
0.37
CC1
0.11
Method
Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.
Top holdings
- Top 10
- 18.9%
- Holdings
- 94
- As of
- 1LENOVO GROUP LTDHK09920090652.91%
- 2SHENZHEN MINDRAY BIO-MEDIC-ACNE100003G671.93%
- 3KANZHUN LTD - ADRUS48553T10601.92%
- 4CHINA YANGTZE PO-ACNE000001G871.88%
- 5MIDEA GROUP CO LTD-ACNE100001QQ51.84%
- 6SHANGHAI UNITED IMAGING HE-ACNE100005PN51.74%
- 7MIDEA GROUP CO LTD-HCNE100006M581.73%
- 8SUNNY OPTICAL TECHKYG8586D10971.70%
- 9KE HOLDINGS INC-CL AKYG5223Y10891.63%
- 10WILL SEMICONDUCTOR CO LTD-ACNE100002XM81.62%
Countries
Classified 99.9%
China99.9%
- Largest
- 99.9%China
- Top 3
- 99.9%
- Effective number
- 1.01 / HHI
Market cap
Weight vs holdings
18.9%of the fund sits in the top 10 holdings
18.9%50.9%30.1%
WeightHoldings
104044
- Holdings 1-10
- Holdings 11-50
- Holdings 51-94
Size split
Not published
Compare ETFs in Copio.
Factual research, without a suitability score or investment recommendation. Past relationships can change.